A look at the strong Q4 report for Veteranpoolen, and the setup for 2026.

Not financial advice.

A short update on the strong Q4 report of the Norwegian medtech company Medistim ASA.

Not financial advice.

An update on Betsson after the poor Q4 report.

A short update on the Q4 and full year report for the concultancy firm Bouvet.

A short update on the Q4 report from Generic AB.

Not financial advice.

Quick recap of the report and my views on the valuation.

Not financial advice.

A short look at the Q3 report from Bergman & Beving.

Let me know if the updates are too short in order to bring any value. I try to focus on the most important things for the stock, in order to respect the listeners time.

As a consequence, reports without much new information, will lead to very short episodes.

A short update on $PDX after shares fell 15% after the Q4 report.

Not financial advice.

Röko was a highly anticipated IPO in 2025. With a strong shareholder base, and the former Lifco CEO at the helm, the company came to market at a high valuation. Could this be a potential long-term compounder after only being established in 2019?

Falling more than 40% since the top, the question remains whether the current valuation is attractive.

Important companies mentioned; Lifco, and Constellation Software.

Not financial advice.

Avtech is a micro cap SAAS-company within the aviation technology space. With strong growth and great margins, this is a potential hidden gem from the swedes.

However, at a market cap of only 460 million SEK, the investment entails substantial risks.

Not financial advice.